ABIGAIL HALL: Open Payments
NPI 1437704699 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$434 in 22 payments from 10 companies in 2025. Trend: 2023 $372 · 2024 $474 · 2025 $434
Food & beverage: $434
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $199 |
| PFIZER INC. | 2 | $57 |
| Edwards Lifesciences Corporation | 1 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Verona Pharma, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Optinose US, Inc. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: Ozempic, NURTEC ODT, SAPIEN 3 Ultra RESILIA, Kerendia, Wegovy, Ohtuvayre, The Cologuard Plus Collection Kit, GVOKE HYPOPEN.
Industry payments across NY — which companies pay providers there.
